GOLDMAN SACHS GROUP INC - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 16 filers reported holding UNICYCIVE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$46,779
-63.7%
93,352
+0.0%
0.00%
Q1 2024$128,808
+59.0%
93,339
-0.0%
0.00%
Q4 2023$80,995
+1.0%
93,344
+0.1%
0.00%
Q3 2023$80,180
-34.7%
93,233
-2.8%
0.00%
Q2 2023$122,79295,9310.00%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Rosalind Advisors, Inc. 1,571,200$787,3280.61%
Vivo Capital, LLC 3,470,152$1,738,8930.16%
Logos Global Management LP 3,469,927$1,738,7800.14%
Nantahala Capital Management 2,820,358$1,413,2820.08%
Monashee Investment Management LLC 1,000,000$501,1000.06%
BVF INC/IL 2,200,000$1,102,4200.03%
RA Capital Management 2,632,200$1,318,9950.02%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$7,0840.00%
Scientech Research LLC 10,969$5,4970.00%
Redwood Wealth Management Group, LLC 3,000$1,5030.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders